undamentalytics Newsletter
Sign in

Trisalus Life Sciences, Inc. revenue

Trisalus Life Sciences, Inc.'s revenue was $45.2m in fiscal 2025, up 53.4% on the year before. Since fiscal 2022 ($12.4m) it has grown at a compound 53.9% a year. Over the last twelve months it was $45.1m.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue1219294545
Growth on the year before—+49.3%+59.0%+53.4%—
Gross profit1016253839
Gross margin81.8%85.9%86.1%84.6%85.8%

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Revenue against peers

Health Care Equipment: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Trisalus Life Sciences, Inc. $45.1m 25.2% 45.1%
Koru Medical Systems, Inc. $45.1m 22.4% 15.3%
Clearpoint Neuro, Inc. $45.5m 32.5% 26.8%
Sanuwave Health, Inc. $44.0m 12.7% 34.4%
Myomo, Inc. $43.3m 6.1% 35.4%
Senseonics Holdings, Inc. $48.5m 90.6% 38.0%

Compare with peers

Head to head: KRMD vs TLSICLPT vs TLSISNWV vs TLSIMYO vs TLSI

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Trisalus Life Sciences, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Trisalus Life Sciences, Inc.